Health Populi January 6, 2025
Jane Sarasohn-Kahn

CES 2025: as you read the acronym and year, your brain registered an image like consumer technology and the start of a new year, or some variation of those thoughts.

When you saw the title of this post with the acronym “GLP-1,” your brain might not have connected the dots between a medicine and “CE,” consumer electronics.

But here we are in real-time, in real life, at the convergence of pharmaceuticals and medicines and consumer-facing technology. And keep in mind that we’re at the annual meeting of CES which is convened by the Consumer Technology Association, CTA.

GLP-1s are showing up at #CES2025 in many ways. Here’s what I’m seeing on the ground, in press releases, and in emailed invitations...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Trendspotting: Predictions for Bio-IT World in 2025
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI
Fierce Biotech Fundraising Tracker '25: Alebund adds $75M; XyloCor raises $67M
J&J says its lung cancer drug combination keeps people alive longer
Will AI revolutionize drug development? Researchers explain why it depends on how it's used

Share This Article